Ovid Therapeutics (OVID) Other Operating Expenses (2016 - 2023)
Ovid Therapeutics (OVID) reported Other Operating Expenses of -$1000.0 for Q1 2023, down 100.48% on a YoY basis from $209050.0 in Q1 2022, and down 100.12% quarter-over-quarter from $836085.0 in Q3 2022.
Ovid Therapeutics (OVID) Other Operating Expenses (2016 - 2023) Analysis & Trends
Ovid Therapeutics has reported Other Operating Expenses for 8 years, with the latest figure at -$1000.0 in Q1 2023.
- For the quarter ending Q1 2023, Other Operating Expenses fell 100.48% year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2023 stood at -$1000.0 (down 100.13% YoY), and the FY2021 full-year result was -$45690.0, down 111.56% from the prior year.
- Other Operating Expenses for Q1 2023 stood at -$1000.0, down from $836085.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $836085.0 in Q3 2022, with the low at -$438260.0 in Q4 2020.
- Historically, Other Operating Expenses has averaged $109971.6 across 5 years, with a median of $3280.0 in 2021.
- Annual changes were most pronounced in 2019 — Other Operating Expenses jumped 58195.11% — and 2022, when it slumped 11188.32%.
- Ovid Therapeutics' Other Operating Expenses stood at $298720.0 in 2019, then tumbled by 246.71% to -$438260.0 in 2020, then soared by 100.89% to $3903.0 in 2021, then soared by 21321.6% to $836085.0 in 2022, then tumbled by 100.12% to -$1000.0 in 2023.
- The last three Other Operating Expenses figures came in at -$1000.0 (Q1 2023), $836085.0 (Q3 2022), and -$284127.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1,000.00 |
| Sep 30, 2022 | 836,085.00 |
| Jun 30, 2022 | -284,127.00 |
| Mar 31, 2022 | 209,050.00 |
| Dec 31, 2021 | 3,903.00 |
| Sep 30, 2021 | 2,657.00 |
| Jun 30, 2021 | -2,517.00 |
| Mar 31, 2021 | -49,732.00 |
| Dec 31, 2020 | -438,260.00 |
| Sep 30, 2020 | -21,127.00 |
| Jun 30, 2020 | 590,491.00 |
| Mar 31, 2020 | 264,296.00 |
| Dec 31, 2019 | 298,720.00 |
| Sep 30, 2019 | 131,164.00 |
| Dec 31, 2018 | -10,296.00 |
| Sep 30, 2018 | 225.00 |
| Jun 30, 2018 | 304.00 |
| Mar 31, 2018 | 136.00 |
| Dec 31, 2017 | -63.00 |
| Sep 30, 2017 | -112.00 |